Common myths about IV ketamine for depressive disorders

Do your patients with depressive disorders or bipolar depression ask you whether intravenous ketamine (off-label) should be considered as a treatment option for them? Due to media coverage, many patients and family members (and even some clinicians) have unrealistic expectations about intravenous ketamine infusions as an off-label treatment for difficult-to-treat (“treatment-resistant”) major depressive disorder. Here…